← FDA Drug Approvals (Drugs@FDA)

CONTRAVE

NDA · New Drug Application · Sponsor: NALPROPION · Approved 2014-09-10

Drug application

FDA Application #

NDA200063

Application type

New Drug Application

Brand name

CONTRAVE

Generic name

NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE

Active ingredients

BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

NALPROPION

Manufacturer

Nalpropion Pharmaceuticals LLC

First approval

2014-09-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown